Status:
UNKNOWN
Effect of DCC on Neonatal Jaundice and Blood Gas Analysis in Infants Born to GDM Mothers
Lead Sponsor:
Second Affiliated Hospital of Wenzhou Medical University
Conditions:
Gestational Diabetes Mellitus
Neonatal Hyperbilirubinemia
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Evidence for benefited newborns following delayed cord clamping (DCC), including increasing hemoglobin and hematocrit levels, improving iron stores, and decreasing need for blood transfusion and incid...
Eligibility Criteria
Inclusion
- People in the study should meet the following inclusion criteria:
- Must be a singleton pregnancy
- Clinical diagnosis of gestational diabetes mellitus according to ACOG Practice Bulletin
Exclusion
- Pregnant women and neonates were excluded if they met the exclusion criteria (not included in if meeting one of following items )
- Maternal clinical diseases (hypertension disorders, abnormal liver function, Rhesus negative blood group or other blood system disease)
- Maternal other pregnancy complications (polyhydramnios, oligohydramnios, placenta praevia, and abruptio placentae).
- Delivery before 37 weeks or after 42 weeks
- Neonatal weight was \< 2.5 kg or\>4.0 kg
- Neonates had major congenital malformations (congenital anal atresia, congenital biliary atresia, congenital heart disease and so on, whether prenatal suspicion or diagnosis postpartum)
- Neonatal septicemia, hemolytic disease or other diseases affecting bilirubin metabolism.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04369313
Start Date
September 1 2019
End Date
April 1 2021
Last Update
March 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
department of obstetrics of Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China, 325027